Skip to main content

Durgam Suresh K.'s Form 4 filing

Intra-Cellular Therapies, Inc.ITCI · filed Jul 20, 2023

Accession no.
0001209191-23-042937
Filed
Jul 20, 2023
Trade date
Jul 17, 2023
Filing delay
3 daysLate
Rule 10b5-1 plan
Checked

This filing lists 1 non-derivative transaction. Open-market sales total $119.7K. It was filed 3 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Durgam Suresh K.CIK 0001829958Officer (EVP, Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 17, 2023Common StockSSaleDisposed−1,842$65.00−$119,73021,262Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)